[1] 李小东, 郭永涛, 张遵城, 等. 125I粒子植入治疗晚期肺癌的损伤效应与临床处置.中华放射医学与防护杂志, 2007, 27(6): 565-567.  doi: 10.3760/cma.j.issn.0254-5098.2007.06.018
[2] Zhongmin W, Yu L, Fenju L, et al. Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. Eur Radiol, 2010, 20(7): 1786-1791.  doi: 10.1007/s00330-009-1703-0
[3] Hilaris BS, Martini N. Interstitial brachytherapy in cancer of the lung: a 20 year experience. Int J Radiat Oncol Biol Phys, 1979, 5(11-12): 1951-1956.  doi: 10.1016/0360-3016(79)90944-1
[4] Parashar B, Patel P, Monni S, et al. Limited resection followed by intraoperative seed implantation is comparable to stereotactic body radiotherapy for solitary lung cancer. Cancer, 2010, 116(21): 5047-5053.  doi: 10.1002/cncr.25441
[5] Nakamura H, Kawasaki N, Hagiwara M, et al. Early hilar lung cancer—risk for multiple lung cancers and clinical outcome. Lung Cancer, 2001, 33(1): 51-57.
[6] 梁吉祥, 柴树德.郑广钧, 等. CT引导下植入125I粒子治疗非小细胞肺癌切除术后局部复发的疗效.国际放射医学核医学杂志, 2011, 35(3): 181-185.  doi: 10.3760/cma.j.issn.1673-4114.2011.03.012
[7] Colonias A, Betler J, Trombetta M, et al. Mature follow-up for high-risk stage Ⅰ non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys, 2011, 79(1): 105-109.  doi: 10.1016/j.ijrobp.2009.10.030
[8] Fernando HC, Landreneau RJ, Mandrekar SJ, et al. Thirty-and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase Ⅲ study. J Thorac Cardiovasc Surg, 2011, 142(5): 1143-1151.  doi: 10.1016/j.jtcvs.2011.07.051
[9] Ye SJ, Brezovich IA, Shen S, et al. Dose errors due to inhomogeneities in balloon catheter brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys, 2004, 60(2): 672-677.  doi: 10.1016/j.ijrobp.2004.05.039
[10] 孙民峰, 郝长城, 梁昌胜, 等. CT引导下125I粒子植入治疗48例肺癌分析.肿瘤学杂志, 2011, 12(17): 951-952.